参考文献
1: Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov;38(8):845-53. doi: 10.1055/s-0032-1328894. Epub 2012 Oct 30. Review. PubMed PMID: 23111862; PubMed Central PMCID: PMC3804561.
2: Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov;38(8):905-7. doi: 10.1055/s-0032-1328890. Epub 2012 Oct 21. Review. PubMed PMID: 23086541; PubMed Central PMCID: PMC3947536.
3: Kaul U, Mansoor AH. Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey. Indian Heart J. 2012 Jan-Feb;64(1):54-9. doi: 10.1016/S0019-4832(12)60012-1. Epub 2012 Mar 26. Review. PubMed PMID: 22572427; PubMed Central PMCID: PMC3861274.
4: Yokoyama T, Usui T, Kiyama K, Nakashima R, Yukawa N, Kawabata D, Nojima T, Ohmura K, Fujii T, Mimori T. Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men. Mod Rheumatol. 2010 Aug;20(4):405-9. doi: 10.1007/s10165-010-0289-3. Epub 2010 Apr 8. Review. PubMed PMID: 20376687.
5: Farid NA, Kurihara A, Wrighton SA. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol. 2010 Feb;50(2):126-42. doi: 10.1177/0091270009343005. Epub 2009 Nov 30. Review. Erratum in: J Clin Pharmacol. 2010 Apr;50(4):483. PubMed PMID: 19948947.
6: Fettser DV, Preobrazhenskiĭ DV, Batyraliev TA, Sidorenko BA, Pataraia SA. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part I. Ticlopidine]. Kardiologiia. 2009;49(4):72-83. Review. Russian. PubMed PMID: 19463124.
7: Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009 Feb;(112):S20-4. doi: 10.1038/ki.2008.613. Review. PubMed PMID: 19180126; PubMed Central PMCID: PMC3500614.
8: Tohgi H. [Ticlopidine]. Nihon Rinsho. 2006 Oct 28;64 Suppl 7:570-5. Review. Japanese. PubMed PMID: 17461207.
9: Kirichenko AA. [Mechanism of action and clinical use of ticlopidine]. Kardiologiia. 2006;46(4):75-80. Review. Russian. PubMed PMID: 16710210.
10: Ikeda U. [Anti-platelet drugs (aspirin, ticlopidine, etc)]. Nihon Rinsho. 2006 Apr;64(4):743-7. Review. Japanese. PubMed PMID: 16613193.
11: Wlazłowski R, Goch A, Goch JH. [Place of ticlopidine in antiplatelet treatment]. Pol Merkur Lekarski. 2005 Aug;19(110):131-5. Review. Polish. PubMed PMID: 16245416.
12: Yagi H. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine]. Rinsho Byori. 2005 Jul;53(7):630-8. Review. Japanese. PubMed PMID: 16104532.
13: Savi P, Herbert JM. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost. 2005 Apr;31(2):174-83. Review. PubMed PMID: 15852221.
14: Jacobson AK. Platelet ADP receptor antagonists: ticlopidine and clopidogrel. Best Pract Res Clin Haematol. 2004 Mar;17(1):55-64. Review. PubMed PMID: 15171957.
15: Baralis G, Steffenino G, Dellavalle A, La Scala E, Uslenghi E. [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?]. Ital Heart J Suppl. 2003 Sep;4(9):766-70. Review. Italian. PubMed PMID: 14635395.
16: Symeonidis A, Kouraklis-Symeonidis A, Seimeni U, Galani A, Giannakoulas N, Fragopanagou E, Tiniakou M, Matsouka P, Zoumbos N. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases. Am J Hematol. 2002 Sep;71(1):24-32. Review. PubMed PMID: 12221670.
17: Pizarro AE, Andrade RJ, García-Cortés M, Lucena MI, Pérez-Moreno JM, Puertas M, Sánchez-Martínez H, Montero JL, Durán JA, Jiménez M, Ruiz-Montero A, Soto-Conesa MJ, Rodrigo L, de Francisco R, Alcántara R, Camargo R. [Acute hepatitis due to ticlopidine. A report of 12 cases and review of the literature]. Rev Neurol. 2001 Dec 1-15;33(11):1014-20. Review. Spanish. PubMed PMID: 11785026.
18: Black C, Paterson KR. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost? Adverse Drug React Toxicol Rev. 2001 Dec;20(4):277-303. Review. PubMed PMID: 11770173.
19: Ha-Duong NT, Dijols S, Macherey AC, Dansette PM, Mansuy D. Inhibition by ticlopidine and its derivatives of human liver cytochrome p450. Mechanism-based inactivation of CYP 2C19 by ticlopidine. Adv Exp Med Biol. 2001;500:145-8. Review. PubMed PMID: 11764927.
20: Cosmi B, Rubboli A, Castelvetri C, Milandri M. Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Database Syst Rev. 2001;(4):CD002133. Review. PubMed PMID: 11687144.
